Welcome to our dedicated page for SCNNF news (Ticker: SCNNF), a resource for investors and traders seeking the latest updates and insights on SCNNF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SCNNF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SCNNF's position in the market.
Goodbody Health has announced a sponsorship agreement with James Hedley for the Formula GB3 2022 Season. Previously, Goodbody Health sponsored Hedley in the 2019 Ginetta Junior Season, where he emerged as champion. In Formula 4 during 2020 and 2021, he continued to excel, winning the Thruxton triple crown and the Peter Collins Trophy. The GB3 Championship races will be broadcasted on ITV, which may enhance brand visibility. Geremy Thomas, Executive Chairman, emphasized the importance of health management in sports as a reason for the sponsorship.
Sativa Wellness Group Inc. is changing its name to Goodbody Health Inc. to better reflect its primary brand. The name change will take effect on January 13, 2022, with shares trading under the new ticker GBDY on the CSE and AQSE. The rebranding aligns with the company's mission to expand its health and wellness offerings, including Covid testing and wellness management services. With over 140 existing clinics, the company aims to reach 1,000 points of care by the end of 2022, enhancing its growth in wellness products and services.
Sativa Wellness Group announced a record week for bookings, exceeding £13.8 million in revenue for the eleven months ending November. The Company operates over 140 clinics in the Goodbody network, including those supporting PCR testing amid new COVID-19 Omicron variant guidelines. Executive Chairman Geremy Thomas expressed confidence in PCR testing's role in managing the virus alongside vaccinations, highlighting the Company's growth.
Sativa Wellness Group announced the application for 1,675,350 common shares to be admitted to the Aquis Stock Exchange and Canadian Securities Exchange, expected on 9 December 2021, contingent on approval. This issuance follows the recent cancellation of 1,329,111 common shares related to a loan cancellation. Post-admission, the company's share capital will total 364,962,152 ordinary shares. Shareholders should use this figure for calculating interests in the company under FCA's rules.
Sativa Wellness Group has announced the appointment of Arden Partners Plc as its new AQSE Corporate Adviser and Broker. Executive Chairman Geremy Thomas expressed optimism, stating this partnership aims to enhance the company's position in the health and wellness market and reflect its value and performance more accurately in the share price. The company has previously noted a disparity between its share price and its underlying value.
Sativa Wellness Group has partnered with Superdrug Stores Plc to provide a range of blood tests across 40 Superdrug locations. Customers can order tests online via the Goodbody Clinic website, with options to select from personal testing or Superdrug clinics. Tests available include Well Woman and Well Man Profiles, Pre-Diabetes, Cholesterol, and Thyroid Function. This partnership aims to enhance customer convenience in managing health and wellness.
Sativa Wellness Group has reported a strong financial performance in Q3 2021, achieving a profit for the second consecutive quarter. Revenue reached C$8.60 million (GBP 5.02 million), soaring 977% compared to Q3 2020, and 724% year-to-date. Q3 gross profit improved to C$4.59 million (GBP 2.68 million), marking a 990% increase from the previous year. The company now operates over 80 clinics and has signed a distribution agreement in Germany. The net profit amounted to C$14,000 (GBP 8,000), a significant turnaround from a C$1.19 million loss last year.
Sativa Wellness Group (OTC PINK:SCNNF) reported a record day with over 850 tests booked, generating approximately C$180,000 (£100,000) in revenue. The majority of tests continue to be COVID-19 related, but blood tests are increasingly in demand. The company expects sustained demand for PCR tests due to government requirements in 220 countries, and anticipates growth in its blood testing services as additional clinics open and test offerings expand. This surge in testing reflects strong operational capacity and customer satisfaction.
Sativa Wellness Group has launched an online telemedicine service named the Virtual GP service, coinciding with the opening of its 70th Goodbody clinic. This service allows customers to follow up on wellness test results through virtual consultations. The company aims to enhance its private healthcare service portfolio under a partnership with ‘The GP Service’. Both Geremy Thomas and Atul Devani expressed enthusiasm about this development, indicating a focus on expanding healthcare access and unique offerings for customers.
